These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 17100937

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
    Sperling H, Debruyne F, Boermans A, Beneke M, Ulbrich E, Ewald S.
    J Sex Med; 2010 Apr; 7(4 Pt 1):1497-507. PubMed ID: 20233275
    [Abstract] [Full Text] [Related]

  • 3. Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naïve men with ED and their partners.
    Edwards D, Hackett G, Collins O, Curram J.
    J Sex Med; 2006 Nov; 3(6):1028-1036. PubMed ID: 17100936
    [Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of vardenafil in East Asian men with erectile dysfunction.
    Chen KK, Paick JS, Ishii N, On Behalf Of The Vardenafil Study Group.
    J Sex Med; 2007 May; 4(3):753-761. PubMed ID: 17498108
    [Abstract] [Full Text] [Related]

  • 5. Vardenafil improved erectile function in a "real-life" broad population study of men with moderate to severe erectile dysfunction in Australia and New Zealand.
    McMahon C, Lording D, Stuckey B, Tan V, Gillman M, White W, Di Natale S, Bramwell P.
    J Sex Med; 2006 Sep; 3(5):892-900. PubMed ID: 16942533
    [Abstract] [Full Text] [Related]

  • 6. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR, Campaña JMC, Ciutat LF, Miranda EF.
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.
    Schneider T, Gleissner J, Merfort F, Hermanns M, Beneke M, Ulbrich E.
    J Sex Med; 2011 Oct; 8(10):2904-11. PubMed ID: 21771281
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives.
    van Ahlen H, Wahle K, Kupper W, Yassin A, Reblin T, Neureither M.
    J Sex Med; 2005 Nov; 2(6):856-64. PubMed ID: 16422810
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of vardenafil and influence on self-esteem and self-confidence in patients with severe erectile dysfunction.
    Martin-Morales A, Meijide F, García N, Artes M, Muñoz A.
    J Sex Med; 2007 Mar; 4(2):440-7. PubMed ID: 17367439
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E, Seftel A, Goldfischer E, Baygani S, Burns P.
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [Abstract] [Full Text] [Related]

  • 13. Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.
    Porst H, Sharlip ID, Hatzichristou D, Rubio-Aurioles E, Gittelman M, Stancil BN, Smith PM, Wilkins HJ, Pommerville P, Vardenafil Study Group.
    Eur Urol; 2006 Nov; 50(5):1086-94; discussion 1094-5. PubMed ID: 16820261
    [Abstract] [Full Text] [Related]

  • 14. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification.
    Donatucci C, Eardley I, Buvat J, Gittelman M, Kell P, Segerson T, Homering M, Montorsi F, Vardenafil Study Group.
    J Sex Med; 2004 Nov; 1(3):301-9. PubMed ID: 16422960
    [Abstract] [Full Text] [Related]

  • 15. Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: a 12-week open-label, multicenter trial.
    Mirone V, Palmieri A, Cucinotta D, Parazzini F, Morelli P, Bettocchi C, Fusco F, Montorsi F.
    J Sex Med; 2005 Nov; 2(6):842-7. PubMed ID: 16422808
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction.
    Ziegler D, Merfort F, Van Ahlen H, Yassin A, Reblin T, Neureither M.
    J Sex Med; 2006 Sep; 3(5):883-891. PubMed ID: 16942532
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.
    Mathers MJ, Klotz T, Brandt AS, Roth S, Sommer F.
    BJU Int; 2008 May; 101(9):1129-34. PubMed ID: 18190629
    [Abstract] [Full Text] [Related]

  • 18. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG, Aliotta P, Auerbach S, Barkin J, Lording D, Murdock M, Wilkins HJ, McBride TA, Colopy MW, Carson CC, Patient Response with Vardenafil in Sildenafil Non-Responders (PROVEN) Study Group.
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [Abstract] [Full Text] [Related]

  • 19. Real-life safety and efficacy of vardenafil in the treatment of erectile dysfunction-results from 30,010 U.S. patients.
    Cheng E.
    J Sex Med; 2007 Mar; 4(2):432-9. PubMed ID: 17087804
    [Abstract] [Full Text] [Related]

  • 20. Do food and dose timing affect the efficacy of sildenafil? A randomized placebo-controlled study.
    Zinner N.
    J Sex Med; 2007 Jan; 4(1):137-144. PubMed ID: 17233779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.